KDM6A-Mediated Expression of the Long Noncoding RNA DINO Causes TP53 Tumor Suppressor Stabilization in Human Papillomavirus 16 E7-Expressing Cells
- 1 June 2020
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 94 (12)
- https://doi.org/10.1128/jvi.02178-19
Abstract
HPV16 E7 has long been noted to stabilize the TP53 tumor suppressor. However, the molecular mechanism of TP53 stabilization by HPV16 E7 has remained obscure and can occur independent of E2F regulated MDM2 inhibitor, p14ARF. Here, we report that the Damage Induced Noncoding (DINO) lncRNA (DINOL) is the missing link between HPV16 E7 and increased TP53 levels. DINO levels are decreased in cells where TP53 is inactivated, either by HPV16 E6, expression of a dominant negative TP53 minigene or by TP53 depletion. DINO levels are increased in HPV16 E7 expressing cells. HPV16 E7 causes increased DINO expression independent of RB1 degradation and E2F1 activation. Similar to the adjacent CDKN1A locus, DINO expression is regulated by the histone demethylase, KDM6A. DINO stabilizes TP53 in HPV16 E7 expressing cells and as a TP53 transcriptional target, DINO levels further increase. Similar to other oncogenes such as adenovirus E1A or MYC, HPV16 E7 expressing cells are sensitized to cell death under conditions of metabolic stress which, in the case of E7 has been linked to TP53 activation. Consistent with earlier studies, we show that HPV16 E7 expressing keratinocytes are highly sensitive to metabolic stress induced by starvation or the antidiabetic drug, metformin. Metabolic stress sensitivity of HPV16 E7 expressing cells to is rescued by DINO depletion. Moreover, DINO depletion decreases sensitivity to the DNA damage inducing chemotherapy agent, doxorubicin. This work identifies DINO as a critical mediator TP53 stabilization and activation in HPV16 E7 expressing cells. IMPORTANCEViral oncoproteins, including HPV16 E6 and E7 have been instrumental in elucidating the activities of cellular signaling networks including those governed by the TP53 tumor suppressor. Our study demonstrates that the long noncoding RNA DINO is the long sought missing link between HPV16 E7 and elevated TP53 levels. Importantly, the TP53 stabilizing DINO plays a critical role in the cell death response of HPV16 E7 expressing cells to metabolic stress or DNA damage.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (CA066980, CA228543)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI147176)
This publication has 50 references indexed in Scilit:
- Landscape of transcription in human cellsNature, 2012
- Interpreting cancer genomes using systematic host network perturbations by tumour virus proteinsNature, 2012
- Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy statusDiabetologia, 2011
- Tumor suppressor p53 meets microRNAsJournal of Molecular Cell Biology, 2011
- Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogrammingProceedings of the National Academy of Sciences of the United States of America, 2011
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 ResponseCell, 2010
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent MannerCell Metabolism, 2010
- Long noncoding RNAs: functional surprises from the RNA worldGenes & Development, 2009
- Expression of the human papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivationVirology, 2009
- Methyl succinate antagonises biguanide‐induced AMPK‐activation and death of pancreatic β‐cells through restoration of mitochondrial electron transferBritish Journal of Pharmacology, 2007